Search Results - "GRUNWALD, Juan E"

Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials by Jaffe, Glenn J., Ying, Gui-Shuang, Toth, Cynthia A., Daniel, Ebenezer, Grunwald, Juan E., Martin, Daniel F., Maguire, Maureen G.

“…To evaluate associations of morphologic features with 5-year visual acuity (VA) in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT)…”
Get full text

Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-related Macular Degeneration Treatments Trials by Sharma, Sumit, MD, Toth, Cynthia A., MD, Daniel, Ebenezer, MBBS, PhD, Grunwald, Juan E., MD, Maguire, Maureen G., PhD, Ying, Gui-Shuang, PhD, Huang, Jiayan, MS, Martin, Daniel F., MD, Jaffe, Glenn J., MD

“…Purpose To describe the association between morphologic features on fundus photography (FP), fluorescein angiography (FA), and optical coherence tomography…”
Get full text

Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials by Grunwald, Juan E., MD, Pistilli, Maxwell, MS, Ying, Gui-shuang, PhD, Maguire, Maureen G., PhD, Daniel, Ebenezer, MBBS, MD, Martin, Daniel F., MD

“…Purpose To evaluate the growth of geographic atrophy (GA) during anti–vascular endothelial growth factor (VEGF) therapy. Design Cohort within a clinical trial…”
Get full text

Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials by Grunwald, Juan E., MD, Daniel, Ebenezer, MBBS, MD, Huang, Jiayan, MS, Ying, Gui-shuang, PhD, Maguire, Maureen G., PhD, Toth, Cynthia A., MD, Jaffe, Glenn J., MD, Fine, Stuart L., MD, Blodi, Barbara, MD, Klein, Michael L., MD, Martin, Alison A, Hagstrom, Stephanie A., PhD, Martin, Daniel F., MD

“…Purpose To describe risk factors for geographic atrophy (GA) in the Comparison of Age-related Macular Degeneration Treatments Trials (CATT). Design Cohort…”
Get full text

Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials by Grunwald, Juan E., MD, Pistilli, Maxwell, MS, Daniel, Ebenezer, MBBS, MD, Ying, Gui-Shuang, PhD, Pan, Wei, MS, Jaffe, Glenn J., MD, Toth, Cynthia A., MD, Hagstrom, Stephanie A., PhD, Maguire, Maureen G., PhD, Martin, Daniel F., MD

“…Purpose To estimate the incidence, size, and growth rate of geographic atrophy (GA) during 5 years of follow-up among participants in the Comparison of…”
Get full text

Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials by Daniel, Ebenezer, MBBS, PhD, Toth, Cynthia A., MD, Grunwald, Juan E., MD, Jaffe, Glenn J., MD, Martin, Daniel F., MD, Fine, Stuart L., MD, Huang, Jiayan, MS, Ying, Gui-shuang, MD, PhD, Hagstrom, Stephanie A., PhD, Winter, Katrina, BS, Maguire, Maureen G., PhD

“…Objective To describe risk factors for scar in eyes treated with ranibizumab or bevacizumab for neovascular age-related macular degeneration (AMD). Design…”
Get full text

Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials by Jaffe, Glenn J., MD, Martin, Daniel F., MD, Toth, Cynthia A., MD, Daniel, Ebenezer, MPH, PhD, Maguire, Maureen G., PhD, Ying, Gui-Shuang, PhD, Grunwald, Juan E., MD, Huang, Jiayan, MS

“…Objective To describe the effects of treatment for 1 year with ranibizumab or bevacizumab on macular morphology and the association of macular morphology with…”
Get full text

Fibroblast Growth Factor-23 and Cardiovascular Events in CKD by SCIALLA, Julia J, HUILIANG XIE, RAJ, Dominic S, WEI YANG, JIANG HE, LASH, James P, GO, Alan S, KUSEK, John W, FELDMAN, Harold, WOLF, Myles, RAHMAN, Mahboob, ANDERSON, Amanda Hyre, ISAKOVA, Tamara, OJO, Akinlolu, XIAOMING ZHANG, NESSEL, Lisa, HAMANO, Takayuki, GRUNWALD, Juan E

“…An elevated level of fibroblast growth factor-23 (FGF-23) is the earliest abnormality of mineral metabolism in CKD. High FGF-23 levels promote left ventricular…”
Get full text

Pseudodrusen and Incidence of Late Age-Related Macular Degeneration in Fellow Eyes in the Comparison of Age-Related Macular Degeneration Treatments Trials by Zhou, Qiang, MD, Daniel, Ebenezer, MBBS, PhD, Maguire, Maureen G., PhD, Grunwald, Juan E., MD, Martin, E. Revell, BA, Martin, Daniel F., MD, Ying, Gui-shuang, PhD

“…Purpose To evaluate the association between pseudodrusen and incidence of late age-related macular degeneration (AMD) in fellow eyes of patients with…”
Get full text

Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) by Daniel, Ebenezer, MPH, PhD, Shaffer, James, MS, Ying, Gui-shuang, PhD, Grunwald, Juan E., MD, Martin, Daniel F., MD, Jaffe, Glenn J., MD, Maguire, Maureen G., PhD

“…Purpose To compare baseline characteristics, visual acuity (VA), and morphologic outcomes between eyes with retinal angiomatous proliferation (RAP) and all…”
Get full text

Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration by Ying, Gui-shuang, PhD, Huang, Jiayan, MS, Maguire, Maureen G., PhD, Jaffe, Glenn J., MD, Grunwald, Juan E., MD, Toth, Cynthia, MD, Daniel, Ebenezer, MBBS, MS, MPH, Klein, Michael, MD, Pieramici, Dante, MD, Wells, John, MD, Martin, Daniel F., MD

“…Objective To determine the baseline predictors of visual acuity (VA) outcomes 1 year after treatment with ranibizumab or bevacizumab for neovascular…”
Get full text

Association between Antiplatelet or Anticoagulant Drugs and Retinal or Subretinal Hemorrhage in the Comparison of Age-Related Macular Degeneration Treatments Trials by Ying, Gui-shuang, PhD, Maguire, Maureen G., PhD, Daniel, Ebenezer, PhD, Grunwald, Juan E., MD, Ahmed, Osama, Martin, Daniel F., MD

“…Purpose To evaluate the association between use of antiplatelet or anticoagulant drugs and retinal or subretinal hemorrhage in participants with neovascular…”
Get full text

Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT) by Ying, Gui-shuang, PhD, Maguire, Maureen G., PhD, Daniel, Ebenezer, MBBS, PhD, Ferris, Frederick L., MD, Jaffe, Glenn J., MD, Grunwald, Juan E., MD, Toth, Cynthia A., MD, Huang, Jiayan, MS, Martin, Daniel F., MD

“…Purpose To evaluate the association of baseline characteristics and early visual acuity (VA) response with visual outcomes at years 1 or 2 in the Comparison of…”
Get full text

Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials by Cuilla, Thomas A., MD, Ying, Gui-shuang, PhD, Maguire, Maureen G., PhD, Martin, Daniel F., MD, Jaffe, Glenn J., MD, Grunwald, Juan E., MD, Daniel, Ebenezer, MBBS, PhD, Toth, Cynthia A., MD

“…Objective To assess the association of the vitreomacular interface with outcomes of eyes treated with anti–vascular endothelial growth factor drugs for…”
Get full text

Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials by Ying, Gui-shuang, Kim, Benjamin J, Maguire, Maureen G, Huang, Jiayan, Daniel, Ebenezer, Jaffe, Glenn J, Grunwald, Juan E, Blinder, Kevin J, Flaxel, Christina J, Rahhal, Firas, Regillo, Carl, Martin, Daniel F

“…Although anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration (AMD) results in improved vision overall, loss of…”
Get more information

SYSTEMIC MEDICATION USE AND THE INCIDENCE AND GROWTH OF GEOGRAPHIC ATROPHY IN THE COMPARISON OF AGE-RELATED MACULAR DEGENERATION TREATMENTS TRIALS by Song, Delu, Hua, Peiying, VanderBeek, Brian L., Dunaief, Joshua L., Grunwald, Juan E., Daniel, Ebenezer, Maguire, Maureen G., Martin, Daniel F., Ying, Gui-Shuang

“…To determine associations of systemic medications with the incidence and growth of geographic atrophy (GA) in participants of the Comparison of Age-related…”
Get full text

Incidence of Choroidal Neovascularization in the Fellow Eye in the Comparison of Age-related Macular Degeneration Treatments Trials by Maguire, Maureen G., PhD, Daniel, Ebenezer, MBBS, PhD, Shah, Ankoor R., MD, Grunwald, Juan E., MD, Hagstrom, Stephanie A., PhD, Avery, Robert L., MD, Huang, Jiayan, MS, Martin, Revell W., BA, Roth, Daniel B., MD, Castellarin, Alessandro A., MD, Bakri, Sophie J., MD, Fine, Stuart L., MD, Martin, Daniel F., MD

“…Objective To assess the influence of drug; dosing regimen; and traditional, nontraditional, and genetic risk factors on the incidence of choroidal…”
Get full text

Photographic Assessment of Baseline Fundus Morphologic Features in the Comparison of Age-related Macular Degeneration Treatments Trials by Grunwald, Juan E., MD, Daniel, Ebenezer, MBBS, PhD, Ying, Gui-shuang, PhD, Pistilli, Maxwell, MS, Med, Maguire, Maureen G., PhD, Alexander, Judith, BA, Whittock-Martin, Revell, BA, Parker, Candace R., BA, Sepielli, Krista, BA, Blodi, Barbara A., MD, Martin, Daniel F., MD

“…Objective To describe the methods used for assessment of baseline fundus characteristics from color photography and fluorescein angiography (FA) in the…”
Get full text

Foveolar Choroidal Circulation and Choroidal Neovascularization in Age-Related Macular Degeneration by Metelitsina, Tatyana I, Grunwald, Juan E, DuPont, Joan C, Ying, Gui-Shuang, Brucker, Alexander J, Dunaief, Joshua L

“…To investigate in a longitudinal study whether foveolar choroidal blood flow changes are associated with the development of choroidal neovascularization (CNV)…”
Get full text

Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials by Shah, Neepa, MD, Maguire, Maureen G., PhD, Martin, Daniel F., MD, Shaffer, James, MS, Ying, Gui-Shuang, PhD, Grunwald, Juan E., MD, Toth, Cynthia A., MD, Jaffe, Glenn J., MD, Daniel, Ebenezer, MBBS, PhD

“…Purpose To describe morphologic and visual outcomes in eyes with angiographic cystoid macular edema (CME) treated with ranibizumab or bevacizumab for…”
Get full text